-
Highlights of the American Hepato-Pancreato-Biliary Association (AHPBA) 2008 Consensus Conference on Resectable and Borderline Resectable Pancreas Cancer
A 1-day consensus conference at the 2008 GCS focused on the latest thinking in resectable and borderline resectable pancreatic cancer.
Conference Coverage, July 2008
-
Does Transfusion With "Old" Blood Place the Surgical Patient at Risk?
Commentary on a study on duration of stored transfusion blood and surgical outcomes, published March 20, 2008 in The New England Journal of Medicine
Expert Viewpoint, July 2008
-
CME
Recent Updates in Anti-angiogenic Therapy for Metastatic Colorectal Cancer
Examine the predictive markers that may allow for better selection of treatment approaches for metastatic colorectal cancer patients.
Slide/Lecture Presentation, July 2008
-
Statins and Prostate Cancer Prevention: Where We Are Now, and Future Directions
Do statins reduce the risk of prostate cancer? Find out how these widely prescribed drugs may be working as double agents.
Journal Article, July 2008
-
Who Picks What You Learn?
It is not the funder of your CME that is crucial -- it's the agenda and the benefit to patient outcomes according to Bob Morrow, MD, in this video blog.
Expert Viewpoint, July 2008
-
A Reply to Thomas Stossel on the AMA-CEJA Draft Report
Rebuttal to Stossel's 12 June commentary responding to CEJA's Draft Report: "Ethical Guidance for Physicians and the Profession With Respect to Industry Support for Professional Education in Medicine"
Expert Viewpoint, July 2008
-
CME
Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office
Alcaligenes xylosoxidans is an uncommon infection in the healthcare setting, but the current study describes how poor infection control practices promoted an outbreak of A xylosoxidans in a major US metropolitan center.
Journal Article, July 2008
-
CME
Biomarkers of Angiogenesis for the Development of Antiangiogenic Therapies in Oncology: Tools or Decorations?
Four antiangiogenesis drugs have been approved for human use in solid tumors but no validated biomarkers are available for routine clinical use. The roles and challenges of developing biomarkers of angiogenesis are reviewed.
Journal Article, July 2008
-
CME
A Case of Synchronous Bilateral Testicular Seminoma
Bilateral synchronous testicular tumors are rare but may require different management from what is routine for unilateral tumors. The current case report features a literature review that examines the best practice for the management of bilateral testicular tumors.
Journal Article, July 2008
-
Emerging Data on Targeted Therapies for Colorectal Cancer: An Expert Interview With Dr. Herbert Hurwitz
Recent colorectal cancer studies are helping to define the role of targeted therapies in the adjuvant setting and delineate how genetic mutations may predict response to targeted treatments.
Expert Viewpoint, June 2008
-
Managing Trastuzumab-Resistant Breast Cancer: An Expert Interview With Dr. Ian Krop
Read about progress being made by researchers who are still pursuing the HER2 target in breast cancer.
Expert Viewpoint, June 2008
-
Hemostatic Monitoring for Cardiothoracic Surgery Patients
Drs. Rodriguez and Ferguson present current strategies for monitoring blood anticoagulation and hemostasis during cardiac surgery.
Expert Viewpoint, June 2008
-
Evolving Role of mTOR Inhibition in the Treatment of Renal Cell Carcinoma: An Expert Interview With Dr. Robert Motzer
In this Expert Interview from ASCO 2008, Dr. Robert Motzer discusses the evolving role of mTOR inhibition in the treatment of renal cell carcinoma, with a focus on the newest agent in the class.
Expert Viewpoint, June 2008
-
CME
Chronic Myelogenous Leukemia in the Age of Targeted Therapy: Recommendations From an Expert Panel
What are the advantages and disadvantages of current methods for testing and monitoring patients with chronic myelogenous leukemia?
Clinical Review, June 2008
-
CME
Penile Rehabilitation Following Radical Prostatectomy
Although nerve-sparing technique has improved outcomes, erectile dysfunction is still common after radical prostatectomy. John Mulhall reviews the latest findings on post-RP penile rehabilitation.
Clinical Review, June 2008
-
CME
ASCO 2008: Novel Approaches to Metastatic Melanoma: Understanding the Potential of Immunotherapy
In this ASCO Spotlight, 3 distinguished melanoma experts focus on current therapies and emerging immunotherapies for patients with metastatic disease.
Commentary, June 2008
-
CME
DDW 2008: Select Topics in GI Oncology -- Issues in CRC and Applications of EUS
Douglas Rex, MD, and Charles J. Lightdale, MD, offer comprehensive clinical discussion on current concepts in GI oncology and applications of EUS, as presented at DDW 2008.
Conference Coverage, June 2008
-
CME
The Emergence of Biomarkers in Treatment for Metastatic Colorectal Cancer: An Expert Interview With Dr. Neal Meropol
In this Expert Interview from ASCO 2008, Dr. Neal Meropol discusses practice-changing implications of newly reported findings regarding K-RAS status and other biomarker assessments.
Conference Coverage, June 2008
-
10th World Congress on Gastrointestinal Cancer
Read clinically focused news coverage of key developments from the meeting.
Conference Coverage, June 2008
-
CME
Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office
Alcaligenes xylosoxidans is an uncommon infection in the healthcare setting, but the current study describes how poor infection control practices promoted an outbreak of A xylosoxidans in a major US metropolitan center.
Journal Article, June 2008
